United States Multicenter Clinical Trial of Corneal Collagen Crosslinking for Keratoconus Treatment.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To evaluate the safety and efficacy of corneal collagen crosslinking (CXL) for the treatment of progressive keratoconus.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Ophthalmology

Title: Ophthalmology

Publisher: Elsevier BV

ISSN (Electronic): 1549-4713

ISSN (Print): 0161-6420

Publication date (Electronic): May 07 2017

Affiliations

[1 ] Cornea and Laser Eye Institute- Hersh Vision Group, CLEI Center for Keratoconus, Teaneck, New Jersey, and the Department of Ophthalmology, Rutgers Medical School, Newark, New Jersey. Electronic address: phersh@vision-institute.com.

[2 ] Stulting Research Center, Woolfson Eye Institute, Atlanta, Georgia.

[3 ] Avedro, Inc., Waltham, Massachusetts.

[4 ] Durrie Vision, Overland Park, Kansas.

[5 ] Avedro, Inc., Waltham, Massachusetts; See Clearly Vision Group, McLean, Virginia.

Article

Publisher Item ID: S0161-6420(16)32110-8

DOI: 10.1016/j.ophtha.2017.03.052

PubMed ID: 28495149

SO-VID: b8060d3a-bca3-460c-ad6c-9de858d14970

History

Data availability:

Comments

Comment on this article

scite_

Cited by 61

See all cited by